New Hypoglycemic Drugs: Combination Drugs and Targets Discovery

New hypoglycemic drugs, including glucagon-like peptide 1 receptor agonists (GLP-1RA), dipeptidyl peptidase-4 inhibitors (DPP-4i) and sodium-glucose cotransporter 2 inhibitors (SGLT-2i), which brings more options for the treatment of type 2 diabetes (T2DM). They are generally well tolerated, althoug...

Descripción completa

Detalles Bibliográficos
Autores principales: Ni, Xiayun, Zhang, Lei, Feng, Xiaojun, Tang, Liqin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295075/
https://www.ncbi.nlm.nih.gov/pubmed/35865956
http://dx.doi.org/10.3389/fphar.2022.877797

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9295075/
https://www.ncbi.nlm.nih.gov/pubmed/35865956
http://dx.doi.org/10.3389/fphar.2022.877797

Ejemplares similares